vs

Side-by-side financial comparison of Genpact LTD (G) and Teradyne (TER). Click either name above to swap in a different company.

Genpact LTD is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.0× Teradyne). Teradyne runs the higher net margin — 31.1% vs 10.8%, a 20.3% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (87.0% vs 5.6%). Over the past eight quarters, Teradyne's revenue compounded faster (32.6% CAGR vs 8.0%).

Genpact Ltd. is an American information technology services, consulting, and outsourcing company headquartered in New York City, New York. Founded in Gurgaon, India, and legally domiciled in Bermuda, Genpact employs more than 125,000 people and provides services to clients in over 30 countries worldwide. Genpact is listed on the NYSE and generated revenues of US$4.48 billion in 2023.

Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.

G vs TER — Head-to-Head

Bigger by revenue
G
G
1.0× larger
G
$1.3B
$1.3B
TER
Growing faster (revenue YoY)
TER
TER
+81.4% gap
TER
87.0%
5.6%
G
Higher net margin
TER
TER
20.3% more per $
TER
31.1%
10.8%
G
Faster 2-yr revenue CAGR
TER
TER
Annualised
TER
32.6%
8.0%
G

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
G
G
TER
TER
Revenue
$1.3B
$1.3B
Net Profit
$143.1M
$398.9M
Gross Margin
36.6%
60.9%
Operating Margin
14.8%
36.9%
Net Margin
10.8%
31.1%
Revenue YoY
5.6%
87.0%
Net Profit YoY
0.8%
EPS (diluted)
$0.82
$2.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
G
G
TER
TER
Q1 26
$1.3B
Q4 25
$1.3B
$1.1B
Q3 25
$1.3B
$769.2M
Q2 25
$1.3B
$651.8M
Q1 25
$1.2B
$685.7M
Q4 24
$1.2B
$752.9M
Q3 24
$1.2B
$737.3M
Q2 24
$1.2B
$729.9M
Net Profit
G
G
TER
TER
Q1 26
$398.9M
Q4 25
$143.1M
$257.2M
Q3 25
$145.8M
$119.6M
Q2 25
$132.7M
$78.4M
Q1 25
$130.9M
$98.9M
Q4 24
$141.9M
$146.3M
Q3 24
$132.8M
$145.6M
Q2 24
$122.0M
$186.3M
Gross Margin
G
G
TER
TER
Q1 26
60.9%
Q4 25
36.6%
57.2%
Q3 25
36.4%
58.4%
Q2 25
35.9%
57.2%
Q1 25
35.3%
60.6%
Q4 24
35.7%
59.4%
Q3 24
35.6%
59.2%
Q2 24
35.4%
58.3%
Operating Margin
G
G
TER
TER
Q1 26
36.9%
Q4 25
14.8%
27.1%
Q3 25
14.8%
18.9%
Q2 25
14.3%
13.9%
Q1 25
15.1%
17.6%
Q4 24
15.2%
20.4%
Q3 24
15.0%
20.6%
Q2 24
14.5%
28.8%
Net Margin
G
G
TER
TER
Q1 26
31.1%
Q4 25
10.8%
23.7%
Q3 25
11.3%
15.5%
Q2 25
10.6%
12.0%
Q1 25
10.8%
14.4%
Q4 24
11.4%
19.4%
Q3 24
11.0%
19.8%
Q2 24
10.4%
25.5%
EPS (diluted)
G
G
TER
TER
Q1 26
$2.53
Q4 25
$0.82
$1.62
Q3 25
$0.83
$0.75
Q2 25
$0.75
$0.49
Q1 25
$0.73
$0.61
Q4 24
$0.80
$0.89
Q3 24
$0.74
$0.89
Q2 24
$0.67
$1.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
G
G
TER
TER
Cash + ST InvestmentsLiquidity on hand
$1.2B
$241.9M
Total DebtLower is stronger
$1.5B
$0
Stockholders' EquityBook value
$2.5B
Total Assets
$5.8B
$4.4B
Debt / EquityLower = less leverage
0.60×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
G
G
TER
TER
Q1 26
$241.9M
Q4 25
$1.2B
$293.8M
Q3 25
$740.8M
$272.7M
Q2 25
$663.3M
$339.3M
Q1 25
$561.6M
$475.6M
Q4 24
$671.6M
$553.4M
Q3 24
$1.0B
$510.0M
Q2 24
$914.2M
$421.9M
Total Debt
G
G
TER
TER
Q1 26
$0
Q4 25
$1.5B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.6B
Q2 24
$1.6B
Stockholders' Equity
G
G
TER
TER
Q1 26
Q4 25
$2.5B
$2.8B
Q3 25
$2.5B
$2.7B
Q2 25
$2.6B
$2.8B
Q1 25
$2.5B
$2.8B
Q4 24
$2.4B
$2.8B
Q3 24
$2.4B
$2.9B
Q2 24
$2.3B
$2.7B
Total Assets
G
G
TER
TER
Q1 26
$4.4B
Q4 25
$5.8B
$4.2B
Q3 25
$5.4B
$4.0B
Q2 25
$5.3B
$3.8B
Q1 25
$4.9B
$3.7B
Q4 24
$5.0B
$3.7B
Q3 24
$5.3B
$3.8B
Q2 24
$5.2B
$3.6B
Debt / Equity
G
G
TER
TER
Q1 26
Q4 25
0.60×
Q3 25
0.47×
Q2 25
0.47×
Q1 25
0.50×
Q4 24
0.51×
Q3 24
0.68×
Q2 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
G
G
TER
TER
Operating Cash FlowLast quarter
$286.7M
$265.1M
Free Cash FlowOCF − Capex
$269.0M
FCF MarginFCF / Revenue
20.4%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.00×
0.66×
TTM Free Cash FlowTrailing 4 quarters
$734.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
G
G
TER
TER
Q1 26
$265.1M
Q4 25
$286.7M
$281.6M
Q3 25
$308.4M
$49.0M
Q2 25
$177.4M
$182.1M
Q1 25
$40.4M
$161.6M
Q4 24
$203.2M
$282.6M
Q3 24
$228.5M
$166.3M
Q2 24
$209.3M
$216.1M
Free Cash Flow
G
G
TER
TER
Q1 26
Q4 25
$269.0M
$218.8M
Q3 25
$292.0M
$2.4M
Q2 25
$155.1M
$131.7M
Q1 25
$18.5M
$97.6M
Q4 24
$183.5M
$225.2M
Q3 24
$208.7M
$114.4M
Q2 24
$190.0M
$171.2M
FCF Margin
G
G
TER
TER
Q1 26
Q4 25
20.4%
20.2%
Q3 25
22.6%
0.3%
Q2 25
12.4%
20.2%
Q1 25
1.5%
14.2%
Q4 24
14.7%
29.9%
Q3 24
17.2%
15.5%
Q2 24
16.2%
23.5%
Capex Intensity
G
G
TER
TER
Q1 26
Q4 25
1.3%
5.8%
Q3 25
1.3%
6.1%
Q2 25
1.8%
7.7%
Q1 25
1.8%
9.3%
Q4 24
1.6%
7.6%
Q3 24
1.6%
7.0%
Q2 24
1.6%
6.1%
Cash Conversion
G
G
TER
TER
Q1 26
0.66×
Q4 25
2.00×
1.09×
Q3 25
2.11×
0.41×
Q2 25
1.34×
2.32×
Q1 25
0.31×
1.63×
Q4 24
1.43×
1.93×
Q3 24
1.72×
1.14×
Q2 24
1.72×
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

G
G

High Tech And Manufacturing$525.3M40%
Consumer And Healthcare$445.8M34%
Financial Services$348.2M26%

TER
TER

Segment breakdown not available.

Related Comparisons